Data integrity – Page 14

GDP CAPA Examples for Repeated Documentation Errors

Case Study on Addressing Repeated Documentation Errors in GDP Compliance In the pharmaceutical manufacturing industry, maintaining compliance with Good Documentation Practices (GDP) is vital for ensuring data integrity and product…

Why Hybrid Records for Contract Labs Happens and How QA Teams Should Control It

Understanding and Controlling Hybrid Records in Contract Labs for Quality Assurance Teams In contemporary pharmaceutical manufacturing, the integration of paper and electronic records, or hybrid records, has emerged as a…

Good Documentation Practices During Regulatory Inspections

Addressing Documentation Issues During Regulatory Inspections Pharmaceutical manufacturing environments are governed by rigorous regulations that demand precise documentation practices. Unfortunately, lapses in documentation can lead to serious compliance issues during…

Inspection-Ready Approach to Hybrid Review Checklist in Pharmaceutical Operations

A Practical Guide to Maintaining Hybrid Review Checklists in Pharmaceutical Operations In an environment where regulatory compliance is paramount, the management of hybrid paper and electronic records can present unique…

How to Strengthen GDP Culture Across Pharma Operations

Enhancing GDP Culture Throughout Pharmaceutical Operations In the pharmaceutical industry, strict adherence to Good Documentation Practices (GDP) and ALCOA+ principles is crucial for compliance and operational efficiency. However, many organizations…

Electronic Calculation with Paper Output: Root Causes, GMP Risks, and CAPA Controls

Investigating the Risks of Hybrid Paper and Electronic GMP Records: Root Causes and Effective CAPA Solutions In today’s pharmaceutical landscape, the integration of hybrid paper and electronic systems has provided…

GDP Compliance for SOPs, Forms, and Attachments

Understanding and Achieving GDP Compliance for SOPs, Forms, and Attachments In the pharmaceutical manufacturing landscape, compliance with Good Documentation Practices (GDP) is not merely a regulatory requirement; it is essential…

How to Prevent Hybrid System Decommissioning in Hybrid Paper–Electronic Systems

Preventing Decommissioning of Hybrid Paper–Electronic Systems in GMP Environments Hybrid paper–electronic systems play a critical role in maintaining data integrity within pharmaceutical manufacturing processes. However, signals of potential decommissioning can…

ALCOA+ Checklist for Batch Record Review Before Release

Essential Steps to Ensure ALCOA+ Compliance During Batch Record Review In the highly regulated pharmaceutical industry, maintaining good documentation practices is non-negotiable for ensuring product integrity and compliance. Regrettably, discrepancies…

Step-by-Step Guide to Managing Hybrid Record Lifecycle Mapping Under ALCOA+ Expectations

Comprehensive Approach to Managing Hybrid Record Lifecycle Mapping Under ALCOA+ Standards In today’s pharmaceutical landscape, the integration of hybrid records—incorporating both paper and electronic elements—has become increasingly prevalent. However, navigating…

How to Investigate Documentation Deviations Using Root Cause Analysis

Understanding the Investigation of Documentation Deviations Through Root Cause Analysis In a recent incident at a mid-sized pharmaceutical manufacturing facility, deviations in documentation practices led to compliance concerns. Batch records…

Why Data Integrity Training for Hybrid Systems Happens and How QA Teams Should Control It

Addressing Data Integrity Challenges in Hybrid Paper–Electronic Systems for GMP Compliance The integration of hybrid paper-electronic systems in pharmaceutical manufacturing is rapidly evolving, yet it exposes organizations to significant risks…